A 12-week treatment with fractional CO<sub>2</sub>laser for vulvovaginal atrophy: a pilot study
Stefano Salvatore(Vita-Salute San Raffaele University), Umberto Leone Roberti Maggiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Simone Ferrero(Ospedale Policlinico San Martino), Alberto Calligaro(University of Pavia), Rossella E. Nappi(University of Pavia), Nicola Zerbinati(University of Insubria), Massimo Candiani(San Raffaele University of Rome), Massimo Origoni(Vita-Salute San Raffaele University)
Cited by 302
Related Papers
ESHRE guideline: endometriosis
|Human Reproduction Open|2022|1.5k
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|350
Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment
|Lasers in Medical Science|2014|265
Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue
|Menopause The Journal of The North American Menopause Society|2015|241
Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies
|Lasers in Surgery and Medicine|2017|239